A comparative study of the effectiveness of cisplatin and 5-fluorouracil on cutaneous squamous human carcinoma cell line: Potential chemotherapy alternative to surgery

被引:7
作者
Gil, S. [1 ]
Yebenes, M. [1 ]
Luelmo, J. [1 ]
Alsina, M. [2 ]
Sabes, M. [3 ]
机构
[1] Hosp Parc Tauli, Dept Dermatol, Sabadell, Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Dermatol, Barcelona, Spain
[3] Univ Autonoma Barcelona, Fac Med, Dept Biophys, Bellaterra, Barcelona, Spain
关键词
5-fluorouracil; cisplatin; cutaneous squamous cell carcinoma; RECOGNITION; DEATH;
D O I
10.1111/dth.12373
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Surgery as treatment for local invasive cutaneous squamous cell carcinoma (cSCC) is not always feasible due to the age and/or the health status of patients. Thus, the investigation of new strategies to improve the quality of life of them is required. The aim of this work is to investigate two chemotherapy agents individually on cSCC cells with the purpose to provide a better understanding of the effectiveness underlying each one. The cisplatin effectiveness is compared at different times with that observed for the 5-fluorouracil treatment. The effectiveness of both was assessed by using flow cytometry to determine the survival cell ratio, and QBlue test to study the cell recovery ability after treatments. A significant increase in the number of apoptotic cells, especially 48 hours after treatments, has been detected. Despite this, cisplatin arises as the most promising agent for the treatment of local invasive cutaneous squamous cell carcinoma due to the fact that a lower concentration and time are required to observe a higher effectiveness on cells with respect to the 5-fluorouracil. An optimal cisplatin-based chemotherapy might provide a better outcome for patients affected by a local invasive cSCC rather than surgery.
引用
收藏
页码:341 / 344
页数:4
相关论文
共 12 条
[1]  
Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1
[2]   Current treatment of cutaneous squamous cancer and molecular strategies for its sensitization to new target-based drugs [J].
Franco, Renato ;
Nicoletti, Gianfranco ;
Lombardi, Angela ;
Di Domenico, Marina ;
Botti, Gerardo ;
Zito Marino, Federica ;
Caraglia, Michele .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (01) :51-66
[3]   Chemoradiation using low-dose cisplatin and 5-fluorouracil in locally advanced squamous cell carcinoma of the skin: A report of two cases [J].
Fujisawa, Yasuhiro ;
Umebayashi, Yoshihiro ;
Ichikawa, Eiko ;
Kawachi, Yasuhiro ;
Otsuka, Fujio .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (05) :S81-S85
[4]   Toxicity of platinum compounds [J].
Hartmann, JT ;
Lipp, HP .
EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (06) :889-901
[5]   Structure, recognition, and processing of cisplatin-DNA adducts [J].
Jamieson, ER ;
Lippard, SJ .
CHEMICAL REVIEWS, 1999, 99 (09) :2467-2498
[6]  
Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P1, DOI 10.1016/s0027-5107(01)00142-7
[7]   CISPLATIN AND 5-FLUOROURACIL FOR METASTATIC SQUAMOUS-CELL CARCINOMA FROM UNKNOWN PRIMARY [J].
KHANSUR, T ;
ALLRED, C ;
LITTLE, D ;
ANAND, V .
CANCER INVESTIGATION, 1995, 13 (03) :263-266
[8]   5-Fluorouracil: Mechanisms of action and clinical strategies [J].
Longley, DB ;
Harkin, DP ;
Johnston, PG .
NATURE REVIEWS CANCER, 2003, 3 (05) :330-338
[9]   Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): A review [J].
Malet-Martino, M ;
Martino, R .
ONCOLOGIST, 2002, 7 (04) :288-323
[10]   Radiochemotherapy Including Cisplatin Alone versus Cisplatin+5-Fluorouracil for Locally Advanced Unresectable Stage IV Squamous Cell Carcinoma of the Head and Neck [J].
Tribius, Silke ;
Kronemann, Stefanie ;
Kilic, Yasemin ;
Schroeder, Ursula ;
Hakim, Samer ;
Schild, Steven E. ;
Rades, Dirk .
STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (10) :675-681